AGT researchers net $4.4m NIH grant
Thursday, 03 July, 2003
Researchers associated with Victorian-based AGT Biosciences have landed a $AUD4.4 million grant from the US National Institutes of Health to fund its human gene discovery research.
The grant, awarded over a period of five years, will be shared between Prof Ahmed Kissebah of the Medical College of Wisconsin, Dr John Blangero of AGT and the Texas-based Southwest Foundation for Biomedical Research, and the AGT team at Deakin University, Geelong.
Prof Greg Collier, AGT's CEO and managing director, said in a statement that the grant was a strong affirmation of AGT's approach to solving problems of complex human diseases.
He said the grant would support a trilateral collaboration between Kissebah (population genetics), Blangero's team (statistical genomics) and AGT's eXpress technology platform.
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
